Trial Profile
A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2015
Price :
$35
*
At a glance
- Drugs Tc 99m ethylenedicysteine deoxyglucose (Primary) ; Fludeoxyglucose F-18
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors CellPoint
- 26 May 2014 New trial record